Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04554693 · ClinicalTrials.gov registry record · Phase 4
The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery
A Phase 4 study of Endometriosis and Endometriosis-related Pain, sponsored by University of Louisville.
- Active
- Registry status
- Phase 4
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT04554693 is a Phase 4 study of Endometriosis and Endometriosis-related Pain that is active but no longer recruiting, run by University of Louisville. The registered enrollment target is 90 participants, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04554693, a Phase 4 study of Endometriosis and Endometriosis-related Pain, is active but no longer recruiting, sponsored by University of Louisville.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Metronidazole Oral
Study Locations (1)
Kentucky
- University of Louisville Hospital - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2020-10-19 |
| Est. Completion | 2027-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04554693
The ClinicalTrials.gov registry entry for NCT04554693 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 48 other Endometriosis trials with a reported enrollment target (66% lower). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04554693 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.
Frequently Asked Questions
What is clinical trial NCT04554693 about?
NCT04554693 is a clinical study titled "The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery". The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.
What is the current status of trial NCT04554693?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 90 participants. The study started on 2020-10-19. Estimated completion is 2027-09.
What conditions does trial NCT04554693 study?
This clinical trial studies the following conditions: Endometriosis, Endometriosis-related Pain.
What interventions are being tested in trial NCT04554693?
The interventions under investigation include: Placebo (DRUG), Metronidazole Oral (DRUG).
Who is sponsoring clinical trial NCT04554693?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04554693 being conducted?
This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometriosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thromboxane Function in Women With Endometriosis
RECRUITING · Phase 4
-
Superior Hypogastric Nerve Plexus Block With Bupivacaine After Robotic Resection of Endometriosis
RECRUITING · Phase 4
-
Endometriosis and Microvascular Dysfunction; Simvastatin and Duavee
RECRUITING · Phase 4
-
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF
COMPLETED · Phase 4
-
Supplementation in Adolescent Girls With Endometriosis
COMPLETED · Phase 4
-
Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.